Related Experiment Video
Updated: Aug 6, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
How Would We Treat Our Own Weaning From Microaxial Flow Pumps for Left Ventricular Unloading?
Maria Benedetto1, Giulia Piccone2, Marta Ferella3
1Cardiothoracic and Vascular Anaesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria Sant'Orsola, Bologna, Italy.
Journal of Cardiothoracic and Vascular Anesthesia
|July 18, 2026
Summary
A new E.R.I.L. protocol offers a personalized strategy for weaning patients from microaxial flow pumps (Impella). This structured approach ensures safe discontinuation, optimizing recovery and minimizing complications.
Area of Science:
- Cardiology
- Mechanical Circulatory Support
- Critical Care Medicine
Background:
- Standard
- one-size-fits-all
- weaning protocols for microaxial flow pumps (Impella) are insufficient.
- Personalized strategies are crucial for safe and effective device discontinuation.
Purpose of the Study:
- To introduce the first structured, stepwise, multimodal, bedside strategy for weaning patients from microaxial flow pumps (Impella).
- To optimize the timing for discontinuation of Impella support, alone or with V-A ECMO (ECPELLA).
- To minimize device-related complications and support sustained left ventricular recovery.
Main Methods:
- The E.R.I.L. protocol integrates echocardiography, patient reconditioning, inotropic support, Impella support, stepwise hemodynamic titration, and lung ultrasound with VExUS.
- This multimodal approach is applied bedside in daily clinical practice.
Main Results:
- The E.R.I.L. protocol provides a framework for identifying optimal Impella discontinuation timing.
- It aims to reduce complications associated with mechanical circulatory support.
- It facilitates sustained left ventricular recovery.
Conclusions:
- The E.R.I.L. protocol represents a novel, personalized approach to weaning patients from microaxial flow pumps.
- Implementing this strategy can improve patient outcomes by ensuring safe and effective device discontinuation.
- This structured protocol addresses the need for individualized care in mechanical circulatory support management.
